Marijke Roos

6.5k total citations · 2 hit papers
56 papers, 5.4k citations indexed

About

Marijke Roos is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Marijke Roos has authored 56 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Virology, 27 papers in Infectious Diseases and 26 papers in Immunology. Recurrent topics in Marijke Roos's work include HIV Research and Treatment (34 papers), HIV/AIDS Research and Interventions (24 papers) and Immune Cell Function and Interaction (14 papers). Marijke Roos is often cited by papers focused on HIV Research and Treatment (34 papers), HIV/AIDS Research and Interventions (24 papers) and Immune Cell Function and Interaction (14 papers). Marijke Roos collaborates with scholars based in Netherlands, United States and Vietnam. Marijke Roos's co-authors include Frank Miedema, Joep M. A. Lange, Dörte Hamann, P T Schellekens, Jaap Goudsmit, Sven A. Danner, Frank Miedema, Nadine G. Pakker, Frank de Wolf and Daan W. Notermans and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Marijke Roos

56 papers receiving 5.2k citations

Hit Papers

Biphasic kinetics of peripheral blood T cells after tripl... 1998 2026 2007 2016 1998 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marijke Roos Netherlands 37 3.3k 2.3k 2.2k 1.4k 520 56 5.4k
Harold A. Kessler United States 39 2.8k 0.8× 2.6k 1.1× 1.1k 0.5× 2.0k 1.4× 716 1.4× 126 5.2k
William Borkowsky United States 39 3.8k 1.2× 2.8k 1.2× 2.6k 1.2× 2.3k 1.6× 779 1.5× 155 6.7k
Yvonne J. Bryson United States 41 2.7k 0.8× 2.8k 1.2× 1.5k 0.7× 2.8k 1.9× 535 1.0× 143 6.3k
Jonathan B. Angel Canada 41 1.7k 0.5× 1.9k 0.9× 1.8k 0.8× 1.4k 1.0× 547 1.1× 177 5.5k
Sandra Burchett United States 41 1.9k 0.6× 3.1k 1.3× 1.2k 0.5× 2.5k 1.8× 627 1.2× 92 5.6k
Homayoon Farzadegan United States 28 2.5k 0.8× 2.9k 1.3× 701 0.3× 1.7k 1.2× 542 1.0× 77 4.9k
Véronique Avettand-Fènoël France 34 2.7k 0.8× 2.3k 1.0× 1.3k 0.6× 846 0.6× 466 0.9× 137 4.0k
Scott F. Sieg United States 36 2.7k 0.8× 1.4k 0.6× 2.6k 1.2× 1.3k 0.9× 1.1k 2.1× 111 5.4k
Deborah K. McMahon United States 29 3.0k 0.9× 3.0k 1.3× 595 0.3× 1.3k 0.9× 810 1.6× 85 4.5k
Patrice Massip France 40 2.3k 0.7× 2.5k 1.1× 492 0.2× 1.0k 0.7× 695 1.3× 127 4.0k

Countries citing papers authored by Marijke Roos

Since Specialization
Citations

This map shows the geographic impact of Marijke Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke Roos more than expected).

Fields of papers citing papers by Marijke Roos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke Roos. The network helps show where Marijke Roos may publish in the future.

Co-authorship network of co-authors of Marijke Roos

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke Roos. A scholar is included among the top collaborators of Marijke Roos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke Roos. Marijke Roos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hendriks, Marleen Elisabeth, Ferdinand W N M Wit, Marijke Roos, et al.. (2012). Hypertension in Sub-Saharan Africa: Cross-Sectional Surveys in Four Rural and Urban Communities. PLoS ONE. 7(3). e32638–e32638. 328 indexed citations
2.
Vossen, Mireille T. M., M.J. van Gent, Jean‐Claude Davin, et al.. (2004). Spontaneous outgrowth of EBV-transformed B-cells reflects EBV-specific immunity in vivo; a useful tool in the follow-up of EBV-driven immunoproliferative disorders in allograft recipients. Transplant International. 17(2). 89–96. 5 indexed citations
3.
Kuijpers, Taco W., Mireille T. M. Vossen, M.J. van Gent, et al.. (2003). Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV. The Journal of Immunology. 170(8). 4342–4348. 134 indexed citations
4.
Hazenberg, Mette D., Sigrid A. Otto, Birgit HB van Benthem, et al.. (2003). Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 17(13). 1881–1888. 577 indexed citations breakdown →
5.
Hazenberg, Mette D., Sigrid A. Otto, Dörte Hamann, et al.. (2003). Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. AIDS. 17(10). 1419–1424. 37 indexed citations
6.
Notermans, Daan W., J J de Jong, Jaap Goudsmit, et al.. (2001). Potent Antiretroviral Therapy Initiates Normalization of Hypergammaglobulinemia and a Decline in HIV Type 1-Specific Antibody Responses. AIDS Research and Human Retroviruses. 17(11). 1003–1008. 67 indexed citations
7.
Reijers, Monique H., Gerrit Jan Weverling, Suzanne Jurriaans, et al.. (2001). The ADAM study continued: maintenance therapy after 50 weeks of induction therapy. AIDS. 15(1). 129–131. 5 indexed citations
8.
Pakker, Nadine G., Marijke Roos, Sigrid A. Otto, et al.. (1999). Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. AIDS. 13(2). 203–212. 87 indexed citations
9.
Rep, M.H.G., Hans M. Schrijver, Rogier Q. Hintzen, et al.. (1999). Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients. Journal of Neuroimmunology. 96(1). 92–100. 104 indexed citations
10.
Kuijpers, Taco W., Albert Wiegman, René A. W. van Lier, et al.. (1999). Kawasaki Disease: A Maturational Defect in Immune Responsiveness. The Journal of Infectious Diseases. 180(6). 1869–1877. 43 indexed citations
11.
Pontesilli, Oscar, Daan W. Notermans, Norbert A. Foudraine, et al.. (1999). Functional T Cell Reconstitution and Human Immunodeficiency Virus–1–Specific Cell‐Mediated Immunity during Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 180(1). 76–86. 103 indexed citations
12.
Froebel, Karin S., Nadine G. Pakker, F Aiuti, et al.. (1999). Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. Journal of Immunological Methods. 227(1-2). 85–97. 29 indexed citations
13.
Prins, Jan M., Suzanne Jurriaans, Rieneke M. E. van Praag, et al.. (1999). Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. AIDS. 13(17). 2405–2410. 193 indexed citations
14.
Beld, Marcel, Maarten Penning, Vladimir V. Lukashov, et al.. (1998). Evidence That both HIV and HIV-Induced Immunodeficiency Enhance HCV Replication among HCV Seroconverters. Virology. 244(2). 504–512. 95 indexed citations
15.
Weverling, Gerrit Jan, Joep M. A. Lange, Suzanne Jurriaans, et al.. (1998). Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. AIDS. 12(11). F117–F122. 89 indexed citations
16.
Wolf, Frank de, Ingrid J. B. Spijkerman, P. T. A. Schellekens, et al.. (1997). AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function. AIDS. 11(15). 1799–1806. 135 indexed citations
17.
Swanink, C.M.A., Jan H. Vercoulen, J M Galama, et al.. (1996). Lymphocyte Subsets, Apoptosis, and Cytokines in Patients with Chronic Fatigue Syndrome. The Journal of Infectious Diseases. 173(2). 460–463. 70 indexed citations
18.
Bindels, Patrick, Anneke Krol, Marijke Roos, et al.. (1995). The Predictive Value of T Cell Function In Vitro and Pre-AIDS Zidovudine Use for Survival after AIDS Diagnosis in a Cohort of Homosexual Men in Amsterdam. The Journal of Infectious Diseases. 172(1). 97–104. 14 indexed citations
19.
Griensven, Frits van, E.M.M. de Vroome, Frank de Wolf, et al.. (1990). RISK FACTORS FOR PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AMONG SEROCONVERTED AND SEROPOSITIVE HOMOSEXUAL MEN. American Journal of Epidemiology. 132(2). 203–210. 42 indexed citations
20.
Wolfs, Tom F.W., Frank de Wolf, C. Breederveld, et al.. (1989). Low AIDS Attack Rate Among Dutch Haemophiliacs Compared to Homosexual Men: A Correlate of HIV Antigenaemia Frequencies. Vox Sanguinis. 57(2). 127–132. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026